| Symbol |
Name |
|
ABCA1
|
ATP-binding cassette, sub-family A (ABC1), member 1
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCE1
|
ATP-binding cassette, sub-family E (OABP), member 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
|
ACPP
|
acid phosphatase, prostate
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ADA
|
adenosine deaminase
|
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1
|
|
ADCY2
|
adenylate cyclase 2 (brain)
|
|
ADCY4
|
adenylate cyclase 4
|
|
ADCY6
|
adenylate cyclase 6
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADIPOR1
|
adiponectin receptor 1
|
|
ADM
|
adrenomedullin
|
|
ADORA1
|
adenosine A1 receptor
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA2B
|
adenosine A2b receptor
|
|
ADORA3
|
adenosine A3 receptor
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHCYL1
|
adenosylhomocysteinase-like 1
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKR1C3
|
aldo-keto reductase family 1, member C3
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ALPL
|
alkaline phosphatase, liver/bone/kidney
|
|
AMH
|
anti-Mullerian hormone
|
|
AMHR2
|
anti-Mullerian hormone receptor, type II
|
|
ANGPT2
|
angiopoietin 2
|
|
ANGPTL2
|
angiopoietin-like 2
|
|
APC
|
adenomatous polyposis coli
|
|
APOC3
|
apolipoprotein C-III
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
|
|
AQP2
|
aquaporin 2 (collecting duct)
|
|
AR
|
androgen receptor
|
|
ARHGAP21
|
Rho GTPase activating protein 21
|
|
ARHGAP35
|
Rho GTPase activating protein 35
|
|
ARRB1
|
arrestin, beta 1
|
|
ASS1
|
argininosuccinate synthase 1
|
|
ATF6
|
activating transcription factor 6
|
|
ATG5
|
autophagy related 5
|
|
ATG7
|
autophagy related 7
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP2C1
|
ATPase, Ca++ transporting, type 2C, member 1
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
B4GALT1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BACE2
|
beta-site APP-cleaving enzyme 2
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BECN1
|
beclin 1, autophagy related
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC2
|
baculoviral IAP repeat containing 2
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRS3
|
bombesin-like receptor 3
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
C2CD2L
|
C2CD2-like
|
|
CALB1
|
calbindin 1, 28kDa
|
|
CAMKK2
|
calcium/calmodulin-dependent protein kinase kinase 2, beta
|
|
CAMP
|
cathelicidin antimicrobial peptide
|
|
CAPN1
|
calpain 1, (mu/I) large subunit
|
|
CARD9
|
caspase recruitment domain family, member 9
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASR
|
calcium-sensing receptor
|
|
CAT
|
catalase
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL13
|
chemokine (C-C motif) ligand 13
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL22
|
chemokine (C-C motif) ligand 22
|
|
CCL23
|
chemokine (C-C motif) ligand 23
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCL3
|
chemokine (C-C motif) ligand 3
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCNT1
|
cyclin T1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CD14
|
CD14 molecule
|
|
CD2
|
CD2 molecule
|
|
CD209
|
CD209 molecule
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD38
|
CD38 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD5
|
CD5 molecule
|
|
CD58
|
CD58 molecule
|
|
CDC42
|
cell division cycle 42
|
|
CDC6
|
cell division cycle 6
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK5R1
|
cyclin-dependent kinase 5, regulatory subunit 1 (p35)
|
|
CDK5R2
|
cyclin-dependent kinase 5, regulatory subunit 2 (p39)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CENPB
|
centromere protein B, 80kDa
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHRNA7
|
cholinergic receptor, nicotinic, alpha 7 (neuronal)
|
|
CHRNE
|
cholinergic receptor, nicotinic, epsilon (muscle)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
CLDN16
|
claudin 16
|
|
CLDN3
|
claudin 3
|
|
CLEC10A
|
C-type lectin domain family 10, member A
|
|
CLEC2D
|
C-type lectin domain family 2, member D
|
|
CLEC7A
|
C-type lectin domain family 7, member A
|
|
CLSPN
|
claspin
|
|
CLU
|
clusterin
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
COX6C
|
cytochrome c oxidase subunit VIc
|
|
COX7B
|
cytochrome c oxidase subunit VIIb
|
|
CRABP1
|
cellular retinoic acid binding protein 1
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSF3
|
colony stimulating factor 3 (granulocyte)
|
|
CSNK1A1
|
casein kinase 1, alpha 1
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTNNBIP1
|
catenin, beta interacting protein 1
|
|
CTSD
|
cathepsin D
|
|
CTSK
|
cathepsin K
|
|
CTSL
|
cathepsin L
|
|
CTSS
|
cathepsin S
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL11
|
chemokine (C-X-C motif) ligand 11
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL14
|
chemokine (C-X-C motif) ligand 14
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DCK
|
deoxycytidine kinase
|
|
DCN
|
decorin
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DHX9
|
DEAH (Asp-Glu-Ala-His) box helicase 9
|
|
DMP1
|
dentin matrix acidic phosphoprotein 1
|
|
DTL
|
denticleless E3 ubiquitin protein ligase homolog (Drosophila)
|
|
DUOX1
|
dual oxidase 1
|
|
DVL1
|
dishevelled segment polarity protein 1
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EDNRB
|
endothelin receptor type B
|
|
EFNA1
|
ephrin-A1
|
|
EFNB2
|
ephrin-B2
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELANE
|
elastase, neutrophil expressed
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
EMD
|
emerin
|
|
ENPP3
|
ectonucleotide pyrophosphatase/phosphodiesterase 3
|
|
EP300
|
E1A binding protein p300
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPHA8
|
EPH receptor A8
|
|
EPHB2
|
EPH receptor B2
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
F10
|
coagulation factor X
|
|
F11R
|
F11 receptor
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL1
|
coagulation factor II (thrombin) receptor-like 1
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FADS1
|
fatty acid desaturase 1
|
|
FADS2
|
fatty acid desaturase 2
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBXO11
|
F-box protein 11
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FEN1
|
flap structure-specific endonuclease 1
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF7
|
fibroblast growth factor 7
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FLNA
|
filamin A, alpha
|
|
FLOT1
|
flotillin 1
|
|
FLOT2
|
flotillin 2
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXO4
|
forkhead box O4
|
|
FPR1
|
formyl peptide receptor 1
|
|
FPR2
|
formyl peptide receptor 2
|
|
FPR3
|
formyl peptide receptor 3
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GADD45A
|
growth arrest and DNA-damage-inducible, alpha
|
|
GAS6
|
growth arrest-specific 6
|
|
GCG
|
glucagon
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GH1
|
growth hormone 1
|
|
GHRH
|
growth hormone releasing hormone
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GIP
|
gastric inhibitory polypeptide
|
|
GLS
|
glutaminase
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNAO1
|
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNLY
|
granulysin
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GOLGA2
|
golgin A2
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPC3
|
glypican 3
|
|
GPHB5
|
glycoprotein hormone beta 5
|
|
GPR17
|
G protein-coupled receptor 17
|
|
GPRC6A
|
G protein-coupled receptor, class C, group 6, member A
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GRHL3
|
grainyhead-like 3 (Drosophila)
|
|
GRM1
|
glutamate receptor, metabotropic 1
|
|
GRM2
|
glutamate receptor, metabotropic 2
|
|
GRPR
|
gastrin-releasing peptide receptor
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSN
|
gelsolin
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
HDAC1
|
histone deacetylase 1
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLF
|
hepatic leukemia factor
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HMGB1
|
high mobility group box 1
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOXB7
|
homeobox B7
|
|
HPX
|
hemopexin
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRH1
|
histamine receptor H1
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPA8
|
heat shock 70kDa protein 8
|
|
HTR1B
|
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled
|
|
HUS1
|
HUS1 checkpoint homolog (S. pombe)
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IER3
|
immediate early response 3
|
|
IFI27
|
interferon, alpha-inducible protein 27
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNL1
|
interferon, lambda 1
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL13
|
interleukin 13
|
|
IL17A
|
interleukin 17A
|
|
IL17F
|
interleukin 17F
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL24
|
interleukin 24
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL3
|
interleukin 3
|
|
IL32
|
interleukin 32
|
|
IL33
|
interleukin 33
|
|
IL34
|
interleukin 34
|
|
IL37
|
interleukin 37
|
|
IL4
|
interleukin 4
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL6R
|
interleukin 6 receptor
|
|
ILK
|
integrin-linked kinase
|
|
INCENP
|
inner centromere protein antigens 135/155kDa
|
|
INHA
|
inhibin, alpha
|
|
INHBA
|
inhibin, beta A
|
|
INHBB
|
inhibin, beta B
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRS1
|
insulin receptor substrate 1
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGA1
|
integrin, alpha 1
|
|
ITGA11
|
integrin, alpha 11
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide)
|
|
ITGA6
|
integrin, alpha 6
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITGB4
|
integrin, beta 4
|
|
JAK1
|
Janus kinase 1
|
|
JARID2
|
jumonji, AT rich interactive domain 2
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KCTD10
|
potassium channel tetramerization domain containing 10
|
|
KDM3A
|
lysine (K)-specific demethylase 3A
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR3DL2
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
|
|
KITLG
|
KIT ligand
|
|
KLF15
|
Kruppel-like factor 15
|
|
KLF9
|
Kruppel-like factor 9
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLRB1
|
killer cell lectin-like receptor subfamily B, member 1
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LAMTOR5
|
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
|
|
LBP
|
lipopolysaccharide binding protein
|
|
LCN2
|
lipocalin 2
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LIF
|
leukemia inhibitory factor
|
|
LIG1
|
ligase I, DNA, ATP-dependent
|
|
LMNA
|
lamin A/C
|
|
LOX
|
lysyl oxidase
|
|
LOXL4
|
lysyl oxidase-like 4
|
|
LPAR1
|
lysophosphatidic acid receptor 1
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRRC32
|
leucine rich repeat containing 32
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTBP3
|
latent transforming growth factor beta binding protein 3
|
|
LTBR
|
lymphotoxin beta receptor (TNFR superfamily, member 3)
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAP2K6
|
mitogen-activated protein kinase kinase 6
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK8IP3
|
mitogen-activated protein kinase 8 interacting protein 3
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAS1
|
MAS1 proto-oncogene, G protein-coupled receptor
|
|
MAS1L
|
MAS1 proto-oncogene like, G protein-coupled receptor
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
ME1
|
malic enzyme 1, NADP(+)-dependent, cytosolic
|
|
MEN1
|
multiple endocrine neoplasia I
|
|
MGAT5B
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR146A
|
microRNA 146a
|
|
MIR223
|
microRNA 223
|
|
MIR34A
|
microRNA 34a
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPO
|
myeloperoxidase
|
|
MRGPRD
|
MAS-related GPR, member D
|
|
MRGPRX2
|
MAS-related GPR, member X2
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC17
|
mucin 17, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MXI1
|
MAX interactor 1, dimerization protein
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYOC
|
myocilin, trabecular meshwork inducible glucocorticoid response
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCSTN
|
nicastrin
|
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase
|
|
NEIL1
|
nei endonuclease VIII-like 1 (E. coli)
|
|
NES
|
nestin
|
|
NET1
|
neuroepithelial cell transforming 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NHEJ1
|
nonhomologous end-joining factor 1
|
|
NLRP1
|
NLR family, pyrin domain containing 1
|
|
NME2
|
NME/NM23 nucleoside diphosphate kinase 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPR1
|
natriuretic peptide receptor 1
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NR1H2
|
nuclear receptor subfamily 1, group H, member 2
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR2E3
|
nuclear receptor subfamily 2, group E, member 3
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRIP1
|
nuclear receptor interacting protein 1
|
|
NSF
|
N-ethylmaleimide-sensitive factor
|
|
NTN1
|
netrin 1
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
OCIAD2
|
OCIA domain containing 2
|
|
OGT
|
O-linked N-acetylglucosamine (GlcNAc) transferase
|
|
OLFM4
|
olfactomedin 4
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
OPA1
|
optic atrophy 1 (autosomal dominant)
|
|
OPRD1
|
opioid receptor, delta 1
|
|
OPRK1
|
opioid receptor, kappa 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
OXT
|
oxytocin/neurophysin I prepropeptide
|
|
P2RX4
|
purinergic receptor P2X, ligand gated ion channel, 4
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY14
|
purinergic receptor P2Y, G-protein coupled, 14
|
|
P2RY6
|
pyrimidinergic receptor P2Y, G-protein coupled, 6
|
|
PADI2
|
peptidyl arginine deiminase, type II
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAK2
|
p21 protein (Cdc42/Rac)-activated kinase 2
|
|
PAK3
|
p21 protein (Cdc42/Rac)-activated kinase 3
|
|
PARN
|
poly(A)-specific ribonuclease
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PCBP2
|
poly(rC) binding protein 2
|
|
PCK2
|
phosphoenolpyruvate carboxykinase 2 (mitochondrial)
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD5
|
programmed cell death 5
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDIA6
|
protein disulfide isomerase family A, member 6
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3
|
|
PGF
|
placental growth factor
|
|
PHB
|
prohibitin
|
|
PHF8
|
PHD finger protein 8
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIK3R3
|
phosphoinositide-3-kinase, regulatory subunit 3 (gamma)
|
|
PIP5K1A
|
phosphatidylinositol-4-phosphate 5-kinase, type I, alpha
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLA2G6
|
phospholipase A2, group VI (cytosolic, calcium-independent)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific)
|
|
PLCH2
|
phospholipase C, eta 2
|
|
PLD1
|
phospholipase D1, phosphatidylcholine-specific
|
|
PLD2
|
phospholipase D2
|
|
PLIN1
|
perilipin 1
|
|
PLP1
|
proteolipid protein 1
|
|
PLTP
|
phospholipid transfer protein
|
|
PML
|
promyelocytic leukemia
|
|
POLH
|
polymerase (DNA directed), eta
|
|
PON1
|
paraoxonase 1
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPIA
|
peptidylprolyl isomerase A (cyclophilin A)
|
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A
|
|
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like
|
|
PPP5C
|
protein phosphatase 5, catalytic subunit
|
|
PREX2
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKACA
|
protein kinase, cAMP-dependent, catalytic, alpha
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCE
|
protein kinase C, epsilon
|
|
PRKD1
|
protein kinase D1
|
|
PRKD2
|
protein kinase D2
|
|
PRKG1
|
protein kinase, cGMP-dependent, type I
|
|
PRL
|
prolactin
|
|
PRLR
|
prolactin receptor
|
|
PRNP
|
prion protein
|
|
PROS1
|
protein S (alpha)
|
|
PSCA
|
prostate stem cell antigen
|
|
PSMB1
|
proteasome (prosome, macropain) subunit, beta type, 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGFR
|
prostaglandin F receptor (FP)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTH
|
parathyroid hormone
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN23
|
protein tyrosine phosphatase, non-receptor type 23
|
|
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRN
|
protein tyrosine phosphatase, receptor type, N
|
|
PUF60
|
poly-U binding splicing factor 60KDa
|
|
PXN
|
paxillin
|
|
PYY
|
peptide YY
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD1
|
RAD1 checkpoint DNA exonuclease
|
|
RAD23B
|
RAD23 homolog B (S. cerevisiae)
|
|
RAD51
|
RAD51 recombinase
|
|
RAD52
|
RAD52 homolog (S. cerevisiae)
|
|
RAD54L2
|
RAD54-like 2 (S. cerevisiae)
|
|
RAD9A
|
RAD9 homolog A (S. pombe)
|
|
RASA4
|
RAS p21 protein activator 4
|
|
RASGEF1B
|
RasGEF domain family, member 1B
|
|
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1
|
|
RBMY1A1
|
RNA binding motif protein, Y-linked, family 1, member A1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
REN
|
renin
|
|
RET
|
ret proto-oncogene
|
|
RETNLB
|
resistin like beta
|
|
RFWD2
|
ring finger and WD repeat domain 2, E3 ubiquitin protein ligase
|
|
RGN
|
regucalcin
|
|
RGS13
|
regulator of G-protein signaling 13
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RHBDL2
|
rhomboid, veinlet-like 2 (Drosophila)
|
|
RHEB
|
Ras homolog enriched in brain
|
|
RHOA
|
ras homolog family member A
|
|
RICTOR
|
RPTOR independent companion of MTOR, complex 2
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RPL29
|
ribosomal protein L29
|
|
RPS6KA4
|
ribosomal protein S6 kinase, 90kDa, polypeptide 4
|
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RPTOR
|
regulatory associated protein of MTOR, complex 1
|
|
RUNX2
|
runt-related transcription factor 2
|
|
RXRA
|
retinoid X receptor, alpha
|
|
RYR2
|
ryanodine receptor 2 (cardiac)
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100A6
|
S100 calcium binding protein A6
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100B
|
S100 calcium binding protein B
|
|
S100G
|
S100 calcium binding protein G
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
SAA1
|
serum amyloid A1
|
|
SAMD9
|
sterile alpha motif domain containing 9
|
|
SCARB1
|
scavenger receptor class B, member 1
|
|
SCNN1A
|
sodium channel, non voltage gated 1 alpha subunit
|
|
SDC1
|
syndecan 1
|
|
SEC22B
|
SEC22 vesicle trafficking protein homolog B (S. cerevisiae) (gene/pseudogene)
|
|
SEC23A
|
Sec23 homolog A (S. cerevisiae)
|
|
SEC61A1
|
Sec61 alpha 1 subunit (S. cerevisiae)
|
|
SELE
|
selectin E
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SELPLG
|
selectin P ligand
|
|
SEMA3A
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A
|
|
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINE2
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SETD8
|
SET domain containing (lysine methyltransferase) 8
|
|
SFRP1
|
secreted frizzled-related protein 1
|
|
SFTPA1
|
surfactant protein A1
|
|
SH3KBP1
|
SH3-domain kinase binding protein 1
|
|
SHH
|
sonic hedgehog
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC12A7
|
solute carrier family 12 (potassium/chloride transporter), member 7
|
|
SLC13A5
|
solute carrier family 13 (sodium-dependent citrate transporter), member 5
|
|
SLC1A2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2
|
|
SLC22A5
|
solute carrier family 22 (organic cation/carnitine transporter), member 5
|
|
SLC22A6
|
solute carrier family 22 (organic anion transporter), member 6
|
|
SLC22A7
|
solute carrier family 22 (organic anion transporter), member 7
|
|
SLC22A8
|
solute carrier family 22 (organic anion transporter), member 8
|
|
SLC26A3
|
solute carrier family 26 (anion exchanger), member 3
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC27A1
|
solute carrier family 27 (fatty acid transporter), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A2
|
solute carrier family 2 (facilitated glucose transporter), member 2
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC39A10
|
solute carrier family 39 (zinc transporter), member 10
|
|
SLC39A6
|
solute carrier family 39 (zinc transporter), member 6
|
|
SLC4A4
|
solute carrier family 4 (sodium bicarbonate cotransporter), member 4
|
|
SLC7A11
|
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SORT1
|
sortilin 1
|
|
SOST
|
sclerostin
|
|
SOX4
|
SRY (sex determining region Y)-box 4
|
|
SOX9
|
SRY (sex determining region Y)-box 9
|
|
SP1
|
Sp1 transcription factor
|
|
SPDEF
|
SAM pointed domain containing ETS transcription factor
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAR
|
steroidogenic acute regulatory protein
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STC1
|
stanniocalcin 1
|
|
STUB1
|
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase
|
|
STX1A
|
syntaxin 1A (brain)
|
|
SUMO1
|
small ubiquitin-like modifier 1
|
|
TBX21
|
T-box 21
|
|
TCEB2P2
|
transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) pseudogene 2
|
|
TDG
|
thymine-DNA glycosylase
|
|
TEAD4
|
TEA domain family member 4
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)
|
|
TFF1
|
trefoil factor 1
|
|
TGFA
|
transforming growth factor, alpha
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB2
|
transforming growth factor, beta 2
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THOP1
|
thimet oligopeptidase 1
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLR2
|
toll-like receptor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TLR5
|
toll-like receptor 5
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP6
|
tumor necrosis factor, alpha-induced protein 6
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF17
|
tumor necrosis factor receptor superfamily, member 17
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TRAF3IP2
|
TRAF3 interacting protein 2
|
|
TRAF3IP3
|
TRAF3 interacting protein 3
|
|
TRAF6
|
TNF receptor-associated factor 6, E3 ubiquitin protein ligase
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSC22D3
|
TSC22 domain family, member 3
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TYMP
|
thymidine phosphorylase
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
USF1
|
upstream transcription factor 1
|
|
USF2
|
upstream transcription factor 2, c-fos interacting
|
|
USP37
|
ubiquitin specific peptidase 37
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCAN
|
versican
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VIPR1
|
vasoactive intestinal peptide receptor 1
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
XAF1
|
XIAP associated factor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XPO1
|
exportin 1
|
|
YAP1
|
Yes-associated protein 1
|
|
YY1
|
YY1 transcription factor
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
